94 related articles for article (PubMed ID: 4032715)
21. [Clinical study of S 6472 granule preparation (sustained-release cefaclor) in chronic respiratory airway infections].
Odagiri S; Matsunaga K; Suzuki K; Murohashi K; Numata H; Takahashi K; Yamaki I; Ishii S
Jpn J Antibiot; 1988 Sep; 41(9):1325-33. PubMed ID: 3241332
[TBL] [Abstract][Full Text] [Related]
22. [Clinical examination of S 6472 (sustained release preparations of cefaclor on chronic respiratory tract infection].
Hayashi I; Ohnuma K
Jpn J Antibiot; 1988 Sep; 41(9):1313-8. PubMed ID: 3241330
[TBL] [Abstract][Full Text] [Related]
23. [Clinical evaluation of S 6472 granule preparation (sustained-release cefaclor) in chronic bronchitis].
Hiraga Y; Omichi M; Sasaoka S
Jpn J Antibiot; 1988 Sep; 41(9):1304-8. PubMed ID: 3241328
[TBL] [Abstract][Full Text] [Related]
24. [Fundamental and clinical studies of S 6472 (sustained release preparation of cefaclor) in the pediatric field].
Sugita M; Toyonaga Y; Nakamura H; Kurosu Y; Hori M
Jpn J Antibiot; 1985 Sep; 38(9):2444-52. PubMed ID: 3908736
[TBL] [Abstract][Full Text] [Related]
25. Phase I study of multiple-dose cefprozil and comparison with cefaclor.
Barbhaiya RH; Shukla UA; Gleason CR; Shyu WC; Wilber RB; Martin RR; Pittman KA
Antimicrob Agents Chemother; 1990 Jun; 34(6):1198-203. PubMed ID: 2393281
[TBL] [Abstract][Full Text] [Related]
26. In vitro activity and pharmacokinetics of cefaclor in normal volunteers and patients with renal failure.
Levison ME; Santoro J; Agarwal BN
Postgrad Med J; 1979; 55 Suppl 4():12-6. PubMed ID: 548939
[TBL] [Abstract][Full Text] [Related]
27. The pharmacokinetics of the oral cephalosporins cefaclor, cephradine and cephalexin.
Welling PG; Dean S; Selen A; Kendall MJ; Wise R
Int J Clin Pharmacol Biopharm; 1979 Sep; 17(9):397-400. PubMed ID: 500261
[TBL] [Abstract][Full Text] [Related]
28. [Comparative pharmacokinetics of oral cephalosporins: cephalexin, cefaclor and cefadroxil (author's transl)].
Lode H; Stahlmann R; Dzwillo G; Koeppe P
Arzneimittelforschung; 1980; 30(3):505-9. PubMed ID: 7387765
[TBL] [Abstract][Full Text] [Related]
29. [Clinical studies of cefaclor for respiratory tract infections].
Hiraga Y; Kikuchi K; Yamamoto A
Jpn J Antibiot; 1984 Apr; 37(4):581-8. PubMed ID: 6471379
[TBL] [Abstract][Full Text] [Related]
30. [Effect of cefaclor in urinary tract infections (2)].
Kajikawa H; Hosokawa S; Kameoka H; Nishimoto N; Miyoshi S; Iwao N; Mizutani S
Jpn J Antibiot; 1984 Aug; 37(8):1453-69. PubMed ID: 6502932
[TBL] [Abstract][Full Text] [Related]
31. An evaluation of the toxicity of cefaclor in laboratory animals.
Hanasono GK; Owen NV; Gibson WR; Hoffman DG; Morton DM
Postgrad Med J; 1979; 55 Suppl 4():17-21. PubMed ID: 121454
[TBL] [Abstract][Full Text] [Related]
32. Pharmacokinetics of cefadroxil and cefaclor during an eight-day dosage period.
Hampel B; Lode H; Wagner J; Koeppe P
Antimicrob Agents Chemother; 1982 Dec; 22(6):1061-3. PubMed ID: 7159069
[TBL] [Abstract][Full Text] [Related]
33. [Investigations on the excretion of cefaclor in human bile (author's transl)].
Müller O; Rückert U; Fabricius K
Infection; 1979; 7 Suppl 6():624-7. PubMed ID: 551091
[TBL] [Abstract][Full Text] [Related]
34. [A double-blind comparison between cefaclor and cephalexin in the treatment of dental infections].
Horii M; Morinaga T; Takeuchi T; Shimada S; Yamanaka H; Nishimura T; Noshi Y; Okada T; Sasaki T; Takada S
Jpn J Antibiot; 1984 Jan; 37(1):152-75. PubMed ID: 6374193
[TBL] [Abstract][Full Text] [Related]
35. Pharmacokinetic analysis of the effects of different foods on absorption of cefaclor.
Oguma T; Yamada H; Sawaki M; Narita N
Antimicrob Agents Chemother; 1991 Sep; 35(9):1729-35. PubMed ID: 1952839
[TBL] [Abstract][Full Text] [Related]
36. [Clinical studies on te concentration of cefaclor in sera and lung tissues of patients with respiratory diseases].
Imaizumi M; Kajita M; Fujita K; Niimi T; Kamiya I; Takahashi T; Asaoka M; Abe T
Jpn J Antibiot; 1986 Oct; 39(10):2754-60. PubMed ID: 3806958
[TBL] [Abstract][Full Text] [Related]
37. A pharmacological study of cefaclor in the newborn infant.
Chin KC; Kerr MM; Cockburn F; McAllister TA
Curr Med Res Opin; 1981; 7(3):168-70. PubMed ID: 7194171
[TBL] [Abstract][Full Text] [Related]
38. Biliary excretion of cefaclor. Experimental and clinical study.
Brogard JM; Pinget M; Comte F; Adloff M; Lavillaureix J
Chemotherapy; 1982; 28(3):189-99. PubMed ID: 7094660
[TBL] [Abstract][Full Text] [Related]
39. [Clinical results of cefaclor treatment of infections of oral regions].
Yoshida Y; Kita T; Kanematsu N; Sato K; Kawata K; Fukuta N; Sato J
Jpn J Antibiot; 1984 Mar; 37(3):318-28. PubMed ID: 6737694
[TBL] [Abstract][Full Text] [Related]
40. [Pharmacokinetics of cefaclor and initial therapeutical experience (author's transl)].
Lode H; Köppe P; Stahlmann R
Infection; 1979; 7 Suppl 6():600-5. PubMed ID: 551086
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
